Published in J Magn Reson Imaging on July 12, 2011
Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging (2012) 1.08
Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging (2012) 0.97
Contrast-enhanced free-breathing 3D T1-weighted gradient-echo sequence for hepatobiliary MRI in patients with breath-holding difficulties. Eur Radiol (2013) 0.95
High resolution navigated three-dimensional T₁-weighted hepatobiliary MRI using gadoxetic acid optimized for 1.5 Tesla. J Magn Reson Imaging (2012) 0.91
Liver-specific agents for contrast-enhanced MRI: role in oncological imaging. Cancer Imaging (2013) 0.84
Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis. J Magn Reson Imaging (2012) 0.82
Effect of hepatocyte-specific gadolinium-based contrast agents on hepatic fat-fraction and R2(⁎). Magn Reson Imaging (2014) 0.78
Liver perfusion in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI): comparison of enhancement in Gd-BT-DO3A and Gd-EOB-DTPA in normal liver parenchyma. Eur Radiol (2014) 0.78
Combined dynamic contrast-enhanced liver MRI and MRA using interleaved variable density sampling. Magn Reson Med (2014) 0.76
Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver Lesions. Semin Roentgenol (2016) 0.75
Gd-EOB-DTPA-Enhanced MR Imaging of the Liver: The Effect on T2 Relaxation Times and Apparent Diffusion Coefficient (ADC). Pol J Radiol (2016) 0.75
Multiple arterial phase MRI of arterial hypervascular hepatic lesions: improved arterial phase capture and lesion enhancement. Abdom Radiol (2016) 0.75
Evaluation of hypointense liver lesions during hepatobiliary phase MR imaging in normal and cirrhotic livers: is increasing flip angle reliable? Sci Rep (2016) 0.75
Contrast-Enhanced Magnetic Resonance Cholangiography: Practical Tips and Clinical Indications for Biliary Disease Management. Gastroenterol Res Pract (2017) 0.75
SENSE: sensitivity encoding for fast MRI. Magn Reson Med (1999) 29.55
Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol (2005) 5.60
Signal-to-noise measurements in magnitude images from NMR phased arrays. Magn Reson Med (1997) 4.56
Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology (1995) 2.38
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol (2007) 2.37
Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn Reson Med (2005) 2.34
Comparison of reconstruction accuracy and efficiency among autocalibrating data-driven parallel imaging methods. Magn Reson Med (2008) 2.32
Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations. Radiology (2004) 2.05
Influence of multichannel combination, parallel imaging and other reconstruction techniques on MRI noise characteristics. Magn Reson Imaging (2008) 1.82
Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology (2005) 1.76
Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology (1996) 1.74
Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology (2005) 1.44
Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther (1999) 1.44
Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol (2008) 1.35
Intracranial time-resolved contrast-enhanced MR angiography at 3T. AJNR Am J Neuroradiol (2006) 1.31
Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study. Radiology (2000) 1.21
Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. Acta Radiol (2007) 1.12
Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. J Comput Assist Tomogr (2010) 1.10
Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers. Acta Radiol (2009) 1.05
Intraindividual comparison of high-spatial-resolution abdominal MR angiography at 1.5 T and 3.0 T: initial experience. Radiology (2007) 1.01
Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol (2003) 1.01
Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Invest Radiol (2011) 0.98
Gadoxetic acid disodium-enhanced magnetic resonance imaging for biliary and vascular evaluations in preoperative living liver donors: comparison with gadobenate dimeglumine-enhanced MRI. J Magn Reson Imaging (2011) 0.96
The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Invest Radiol (2008) 0.92
Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging. Eur Radiol (2010) 0.91
Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT. Radiology (2009) 0.90
Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging. Invest Radiol (1993) 0.90
Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers. AJR Am J Roentgenol (1992) 0.89
A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. J Comput Assist Tomogr (1998) 0.88
High spatial resolution T1-weighted MR imaging of liver and biliary tract during uptake phase of a hepatocyte-specific contrast medium. Invest Radiol (2008) 0.88
Contrast-enhanced abdominal MR angiography: optimization of imaging delay time by automating the detection of contrast material arrival in the aorta. Radiology (1997) 0.87
Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA). J Magn Reson Imaging (1999) 0.81
Bilateral ce-MR angiography of the hands at 3.0 T and 1.5 T: intraindividual comparison of quantitative and qualitative image parameters in healthy volunteers. Eur Radiol (2007) 0.79
Contrast-enhanced MR imaging of the liver: comparison between Gd-BOPTA and Mangafodipir. J Magn Reson Imaging (1997) 0.78
Variable echo time imaging: signal characteristics of 1-M gadobutrol contrast agent at 1.5 and 3T. Magn Reson Med (2008) 0.78
Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model. Acad Radiol (2007) 0.77
Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med (2008) 4.50
Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging (2007) 4.18
Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med (2007) 3.88
Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging (2007) 3.79
Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology (2011) 3.08
Field map estimation with a region growing scheme for iterative 3-point water-fat decomposition. Magn Reson Med (2005) 2.82
Cramér-Rao bounds for three-point decomposition of water and fat. Magn Reson Med (2005) 2.63
Referenceless PRF shift thermometry. Magn Reson Med (2004) 2.31
T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging (2011) 2.27
Effects of refocusing flip angle modulation and view ordering in 3D fast spin echo. Magn Reson Med (2008) 1.96
Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging (2012) 1.90
Influence of multichannel combination, parallel imaging and other reconstruction techniques on MRI noise characteristics. Magn Reson Imaging (2008) 1.82
T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: validation in a fat-water-SPIO phantom. J Magn Reson Imaging (2009) 1.71
Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction. Magn Reson Med (2011) 1.67
Fat and water magnetic resonance imaging. J Magn Reson Imaging (2010) 1.64
Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology (2010) 1.53
Cardiac MRI of ischemic heart disease at 3 T: potential and challenges. Eur J Radiol (2008) 1.40
Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol (2009) 1.39
Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am (2010) 1.37
Generalized k-space decomposition with chemical shift correction for non-Cartesian water-fat imaging. Magn Reson Med (2008) 1.34
Cardiac CINE MR imaging with a 32-channel cardiac coil and parallel imaging: impact of acceleration factors on image quality and volumetric accuracy. J Magn Reson Imaging (2006) 1.25
Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging (2010) 1.23
Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology (2012) 1.23
4D cardiovascular magnetic resonance velocity mapping of alterations of right heart flow patterns and main pulmonary artery hemodynamics in tetralogy of Fallot. J Cardiovasc Magn Reson (2012) 1.23
Water-fat separation with bipolar multiecho sequences. Magn Reson Med (2008) 1.22
Independent estimation of T*2 for water and fat for improved accuracy of fat quantification. Magn Reson Med (2010) 1.13
Articular cartilage of the knee: rapid three-dimensional MR imaging at 3.0 T with IDEAL balanced steady-state free precession--initial experience. Radiology (2006) 1.11
3.0-T evaluation of knee cartilage by using three-dimensional IDEAL GRASS imaging: comparison with fast spin-echo imaging. Radiology (2010) 1.09
Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging (2012) 1.08
Renal arteries: isotropic, high-spatial-resolution, unenhanced MR angiography with three-dimensional radial phase contrast. Radiology (2010) 1.08
Validation of MRI biomarkers of hepatic steatosis in the presence of iron overload in the ob/ob mouse. J Magn Reson Imaging (2011) 1.08
R*(2) mapping in the presence of macroscopic B₀ field variations. Magn Reson Med (2011) 1.06
Single breathhold cardiac CINE imaging with multi-echo three-dimensional hybrid radial SSFP acquisition. J Magn Reson Imaging (2010) 1.05
Noninvasive temperature mapping with MRI using chemical shift water-fat separation. Magn Reson Med (2010) 1.05
In vivo MR thermometry of frozen tissue using R2* and signal intensity. Acad Radiol (2005) 1.04
Single acquisition water-fat separation: feasibility study for dynamic imaging. Magn Reson Med (2006) 1.03
Phase and amplitude correction for multi-echo water-fat separation with bipolar acquisitions. J Magn Reson Imaging (2010) 1.02
In vivo validation of 4D flow MRI for assessing the hemodynamics of portal hypertension. J Magn Reson Imaging (2012) 1.02
Multipeak fat-corrected complex R2* relaxometry: theory, optimization, and clinical validation. Magn Reson Med (2013) 1.02
Constraining the initial phase in water-fat separation. Magn Reson Imaging (2010) 1.02
Noninvasive assessment of transstenotic pressure gradients in porcine renal artery stenoses by using vastly undersampled phase-contrast MR angiography. Radiology (2011) 1.01
T(2)-weighted 3D fast spin echo imaging with water-fat separation in a single acquisition. J Magn Reson Imaging (2010) 1.01
IDEAL imaging of the musculoskeletal system: robust water fat separation for uniform fat suppression, marrow evaluation, and cartilage imaging. AJR Am J Roentgenol (2007) 1.00
Quantification of thoracic blood flow using volumetric magnetic resonance imaging with radial velocity encoding: in vivo validation. Invest Radiol (2013) 0.99
The influence of prior hamstring injury on lengthening muscle tissue mechanics. J Biomech (2010) 0.98
Interleaved variable density sampling with a constrained parallel imaging reconstruction for dynamic contrast-enhanced MR angiography. Magn Reson Med (2011) 0.98
Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging (2012) 0.97
Increased volume of coverage for abdominal contrast-enhanced MR angiography with two-dimensional autocalibrating parallel imaging: initial experience at 3.0 Tesla. J Magn Reson Imaging (2009) 0.96
Effects of postprandial state and mesenteric blood flow on the repeatability of MR elastography in asymptomatic subjects. J Magn Reson Imaging (2011) 0.95
Quantification of liver iron with MRI: state of the art and remaining challenges. J Magn Reson Imaging (2014) 0.94
Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging (2013) 0.94
Comparison of R2* correction methods for accurate fat quantification in fatty liver. J Magn Reson Imaging (2012) 0.94
Simultaneous estimation of tongue volume and fat fraction using IDEAL-FSE. J Magn Reson Imaging (2008) 0.93
Cardiac steady-state free precession CINE magnetic resonance imaging at 3.0 tesla: impact of parallel imaging acceleration on volumetric accuracy and signal parameters. Invest Radiol (2006) 0.92
Variations in T(2)* and fat content of murine brown and white adipose tissues by chemical-shift MRI. Magn Reson Imaging (2012) 0.92
Improved least squares MR image reconstruction using estimates of k-space data consistency. Magn Reson Med (2011) 0.91
Adipose tissue MRI for quantitative measurement of central obesity. J Magn Reson Imaging (2012) 0.91
High resolution navigated three-dimensional T₁-weighted hepatobiliary MRI using gadoxetic acid optimized for 1.5 Tesla. J Magn Reson Imaging (2012) 0.91
Presurgical localization of the artery of Adamkiewicz with time-resolved 3.0-T MR angiography. Radiology (2010) 0.91
Noise analysis for 3-point chemical shift-based water-fat separation with spectral modeling of fat. J Magn Reson Imaging (2010) 0.89
Targeted transendocardial therapeutic delivery guided by MRI-x-ray image fusion. Catheter Cardiovasc Interv (2011) 0.89
Flow-independent T(2)-prepared inversion recovery black-blood MR imaging. J Magn Reson Imaging (2010) 0.89
Balanced SSFP imaging of the musculoskeletal system. J Magn Reson Imaging (2007) 0.89
Effectiveness of MR angiography for the primary diagnosis of acute pulmonary embolism: clinical outcomes at 3 months and 1 year. J Magn Reson Imaging (2013) 0.88
Improved fat suppression using multipeak reconstruction for IDEAL chemical shift fat-water separation: application with fast spin echo imaging. J Magn Reson Imaging (2009) 0.88
High-spatial and high-temporal resolution dynamic contrast-enhanced perfusion imaging of the liver with time-resolved three-dimensional radial MRI. Magn Reson Med (2014) 0.88
Multiecho IDEAL gradient-echo water-fat separation for rapid assessment of cartilage volume at 1.5 T: initial experience. Radiology (2009) 0.88
Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol (2015) 0.88
Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob mouse. Invest Radiol (2012) 0.87
Cartilage imaging at 3.0T with gradient refocused acquisition in the steady-state (GRASS) and IDEAL fat-water separation. J Magn Reson Imaging (2008) 0.87
Phase-sensitive inversion recovery (PSIR) single-shot TrueFISP for assessment of myocardial infarction at 3 tesla. Invest Radiol (2006) 0.87
On the confounding effect of temperature on chemical shift-encoded fat quantification. Magn Reson Med (2013) 0.87
Body MRI using IDEAL. AJR Am J Roentgenol (2008) 0.87
Pulmonary perfusion MRI using interleaved variable density sampling and HighlY constrained cartesian reconstruction (HYCR). J Magn Reson Imaging (2013) 0.86
Cartilage morphology at 3.0T: assessment of three-dimensional magnetic resonance imaging techniques. J Magn Reson Imaging (2010) 0.86
Percutaneous augmentation of the superior pubic ramus with polymethyl methacrylate: treatment of acute traumatic and chronic insufficiency fractures. Skeletal Radiol (2007) 0.86
Cine flow measurements using phase contrast with undersampled projections: in vitro validation and preliminary results in vivo. J Magn Reson Imaging (2006) 0.85
R2* estimation using "in-phase" echoes in the presence of fat: the effects of complex spectrum of fat. J Magn Reson Imaging (2012) 0.85
Controversies in protocol selection in the imaging of articular cartilage. Semin Musculoskelet Radiol (2005) 0.85
Effect of temporal resolution on 4D flow MRI in the portal circulation. J Magn Reson Imaging (2013) 0.84
Improving chemical shift encoded water-fat separation using object-based information of the magnetic field inhomogeneity. Magn Reson Med (2014) 0.84
Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma. J Magn Reson Imaging (2014) 0.84
Design of k-space channel combination kernels and integration with parallel imaging. Magn Reson Med (2013) 0.84
Percutaneous treatment of insufficiency fractures : principles, technique and review of literature. Skeletal Radiol (2010) 0.83
Improved delayed enhanced myocardial imaging with T2-Prep inversion recovery magnetization preparation. J Magn Reson Imaging (2008) 0.83
Multimodality image fusion to guide peripheral artery chronic total arterial occlusion recanalization in a swine carotid artery occlusion model: unblinding the interventionalist. Catheter Cardiovasc Interv (2012) 0.83
Fat confounds the observed apparent diffusion coefficient in patients with hepatic steatosis. Magn Reson Med (2012) 0.83
Three-dimensional pulmonary perfusion MRI with radial ultrashort echo time and spatial-temporal constrained reconstruction. Magn Reson Med (2014) 0.82
High-resolution 3D cartilage imaging with IDEAL SPGR at 3 T. AJR Am J Roentgenol (2007) 0.82
Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications. AJR Am J Roentgenol (2014) 0.82
Water-silicone separated volumetric MR acquisition for rapid assessment of breast implants. J Magn Reson Imaging (2012) 0.82
Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis. J Magn Reson Imaging (2012) 0.82
Ethnic differences in the effects of hepatic fat deposition on insulin resistance in nonobese middle school girls. Obesity (Silver Spring) (2013) 0.82
Oxygen-enhanced 3D radial ultrashort echo time magnetic resonance imaging in the healthy human lung. NMR Biomed (2014) 0.82
Exercise-induced bronchoconstriction: reproducibility of hyperpolarized 3He MR imaging. Radiology (2012) 0.82